Smurfit WestRock
SW
41.29
-1.10
-2.60%
Smurfit WestRock
US · SW
#840 by market cap
Listed 2015
41.29
-1.10
-2.60%
Live - 5344 symbols - heartbeat 401s ago
· 2026-10-08 07:00
Pre-market
40.35
-2.28%
After-hours
41.29
0.00%
Overnight
41.00
-0.70%
- Market cap
- 21.66B
- P/E (TTM)i
- 43.93
- P/Bi
- 1.20
- EPSi
- 1.33
- Div yieldi
- 4.28%
- 52W posi
- 48%
Reader sentiment
Are you bullish or bearish on SW?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.51, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +47.70% YoY
Margins
- Gross margin
- 19.38%
- Operating margin
- 7.13%
- Net margin
- 2.24%
Key ratios & quality
- Enterprise valuei
- 34.54B
- Altman Z-Scorei
- 1.51
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.23B | 10.14B | 10.49B | 11.44B | 13.51B | 12.09B | 21.11B | 31.18B |
| Gross profit | 3.38B | 3.37B | 3.53B | 3.50B | 3.27B | 3.05B | 4.20B | 6.04B |
| Selling & admin expenses | 2.12B | 2.18B | 2.40B | 2.29B | 1.54B | 1.57B | 2.74B | 3.82B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.26B | 1.19B | 1.13B | 1.21B | 1.73B | 1.48B | 1.46B | 2.22B |
| Pretax profit | -462.14M | 758.36M | 920.00M | 1.03B | 1.43B | 1.14B | 560.00M | 959.00M |
| Tax | 268.82M | 216.19M | 247.22M | 264.94M | 391.00M | 312.00M | 241.00M | 260.00M |
| Net profit | -730.95M | 542.16M | 672.78M | 768.78M | 1.04B | 826.00M | 319.00M | 699.00M |
| Basic EPS | -3 | 2 | 3 | 3 | 4 | 3 | 1 | 1 |
| Diluted EPS | -3.13 | 2.24 | 2.78 | 2.96 | 3.96 | 3.17 | 0.82 | 1.33 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 7.66B | 7.94B | 8.00B | 7.58B | 7.71B | 8.03B |
| Gross profit | 1.58B | 1.52B | 1.57B | 1.38B | 1.27B | 1.40B |
| Selling & admin expenses | 973.00M | 963.00M | 963.00M | 920.00M | 961.00M | 970.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 604.00M | 552.00M | 606.00M | 462.00M | 307.00M | 429.00M |
| Pretax profit | 390.00M | 58.00M | 336.00M | 175.00M | 84.00M | 128.00M |
| Tax | 8.00M | 84.00M | 91.00M | 77.00M | 21.00M | 40.00M |
| Net profit | 382.00M | -26.00M | 245.00M | 98.00M | 63.00M | 88.00M |
| Basic EPS | 1 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.73 | -0.05 | 0.47 | 0.18 | 0.12 | 0.17 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.38B | 3.00B | 4.01B | 4.62B | 4.84B | 4.57B | 10.06B | 10.44B |
| Cash & ST investments | 465.57M | 211.71M | 1.10B | 983.90M | 833.25M | 1.00B | 855.00M | 892.00M |
| Inventory | 981.47M | 929.74M | 964.28M | 1.20B | 1.33B | 1.20B | 3.55B | 3.69B |
| Total assets | 10.86B | 11.12B | 12.66B | 13.25B | 13.39B | 14.05B | 43.76B | 45.16B |
| Total current liabilities | 2.43B | 2.48B | 2.74B | 3.20B | 3.25B | 3.01B | 7.33B | 7.06B |
| Short-term debt | 191.03M | 207.23M | 189.41M | 186.82M | 193.03M | 78.00M | 1.05B | 346.00M |
| Long-term debt | 3.86B | 3.92B | 3.84B | 4.06B | 3.86B | 3.67B | 12.54B | 13.43B |
| Total liabilities | 7,553,191,489.36 | 7,765,032,709.02 | 8,003,296,270.79 | 8,282,194,696.68 | 7,982,927,430.86 | 7,877,000,000.00 | 26,372,000,000.00 | 26,803,000,000.00 |
| Total equity | 3.31B | 3.35B | 4.65B | 4.97B | 5.40B | 6.17B | 17.39B | 18.35B |
| Retained earnings | 480.44M | 688.91M | 1.13B | 1.67B | 2.30B | 3.52B | 2.95B | 2.66B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 10.63B | 10.98B | 10.88B | 10.44B | 10.55B | 10.82B |
| Cash & ST investments | 797.00M | 778.00M | 851.00M | 892.00M | 674.00M | 677.00M |
| Inventory | 3.67B | 3.77B | 3.78B | 3.69B | 3.58B | 3.61B |
| Total assets | 44.65B | 45.75B | 45.57B | 45.16B | 45.17B | 45.20B |
| Total current liabilities | 7.45B | 7.59B | 7.35B | 7.06B | 7.31B | 7.48B |
| Short-term debt | 1.30B | 1.03B | 798.00M | 346.00M | 980.00M | 931.00M |
| Long-term debt | 12.92B | 13.33B | 13.31B | 13.43B | 13.28B | 13.23B |
| Total liabilities | 26,760,000,000.00 | 27,422,000,000.00 | 27,110,000,000.00 | 26,803,000,000.00 | 27,087,000,000.00 | 27,141,000,000.00 |
| Total equity | 17.89B | 18.32B | 18.46B | 18.35B | 18.08B | 18.06B |
| Retained earnings | 3.03B | 2.77B | 2.79B | 2.66B | 2.40B | 2.24B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.18B | 1.30B | 1.53B | 1.12B | 1.43B | 1.56B | 1.48B | 3.39B |
| Depreciation & amortization | 479.30M | 606.01M | 685.08M | 626.12M | 564.00M | 580.00M | 1.46B | 2.55B |
| Free cash flow | 549.07M | 594.81M | 901.55M | 420.05M | 503.00M | 630.00M | 17.00M | 1.20B |
| Dividends paid | -243.65M | -266.60M | -319.79M | -341.93M | -349.00M | -391.00M | -650.00M | -900.00M |
| Stock buybacks / issuance | -11.44M | -23.52M | 777.33M | -24.91M | -74.00M | -30.00M | -27.00M | 0 |
| Ending cash balance | 446.12M | 192.67M | 1.08B | 952.20M | 841.00M | 1.00B | 855.00M | 892.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 235.00M | 829.00M | 1.13B | 1.20B | 204.00M | 765.00M |
| Depreciation & amortization | 603.00M | 613.00M | 659.00M | 675.00M | 728.00M | 678.00M |
| Free cash flow | -242.00M | 307.00M | 523.00M | 612.00M | -420.00M | 300.00M |
| Dividends paid | -225.00M | -225.00M | -225.00M | -225.00M | -237.00M | -237.00M |
| Stock buybacks / issuance | 0 | 0 | 0 | 0 | 14.00M | 0 |
| Ending cash balance | 797.00M | 778.00M | 851.00M | 892.00M | 674.00M | 677.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -23.97 | 16.50 | 16.88 | 16.02 | 19.57 | 14.53 | 2.71 | 3.92 |
| ROA %i | -6.82 | 4.85 | 5.64 | 5.93 | 7.60 | 6.13 | 1.11 | 1.57 |
| ROIC %i | -7.88 | 9.30 | 9.86 | 9.78 | 12.11 | 9.64 | 3.24 | 3.90 |
| 5-year avg ROE %i | 8.17 | 9.48 | 9.41 | 8.75 | 9.08 | 16.74 | 13.98 | 11.39 |
| EBIT margin %i | -2.48 | 9.56 | 10.41 | 10.30 | 11.32 | 10.94 | 5.14 | 5.77 |
| FCF / sales %i | 5.37 | 5.87 | 8.59 | 3.67 | 4.39 | 5.84 | 0.08 | 3.85 |
| Current ratioi | 1.39 | 1.21 | 1.46 | 1.44 | 1.49 | 1.52 | 1.37 | 1.48 |
| Quick ratioi | 0.95 | 0.79 | 1.05 | 1.03 | 1.01 | 0.93 | 0.68 | 0.73 |
| Debt / assetsi | 37.28 | 37.14 | 31.84 | 32.07 | 30.28 | 26.67 | 31.07 | 30.50 |
| LT debt / equityi | 122.22 | 118.60 | 82.81 | 81.96 | 71.64 | 59.58 | 72.25 | 73.26 |
| Interest coveragei | -1.22 | 4.60 | 6.34 | 8.13 | 9.18 | 6.93 | 2.07 | 2.14 |
| Revenue CAGR (3Y) %i | 4.90 | 5.71 | 0.71 | 3.80 | 10.05 | 4.85 | 22.64 | 32.15 |
| Net income CAGR (3Y) %i | -- | 4.52 | 10.24 | -- | 24.70 | 7.17 | -25.41 | -12.24 |
| FCF CAGR (3Y) %i | 13.89 | 24.37 | 38.15 | -8.54 | -5.44 | -11.26 | -65.67 | 33.62 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 2.87 | 1.92 | 4.11 | 3.92 | 2.12 | 2.74 |
| ROA %i | 1.15 | 0.77 | 1.65 | 1.57 | 0.85 | 1.09 |
| ROIC %i | 2.85 | 2.42 | 3.93 | 3.90 | 2.54 | 3.29 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.29 | 4.45 | 5.84 | 5.77 | 4.79 | 4.98 |
| FCF / sales %i | -- | 0.28 | 2.57 | 3.85 | 3.27 | 3.24 |
| Current ratioi | 1.43 | 1.45 | 1.48 | 1.48 | 1.44 | 1.45 |
| Quick ratioi | 0.72 | 0.74 | 0.75 | 0.73 | 0.73 | 0.75 |
| Debt / assetsi | 31.85 | 31.40 | 30.97 | 30.50 | 31.56 | 31.34 |
| LT debt / equityi | 72.32 | 72.85 | 72.22 | 73.26 | 73.51 | 73.37 |
| Interest coveragei | 2.00 | 1.68 | 2.24 | 2.14 | 1.77 | 1.86 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Packaging is the largest reported line at 80.26% of revenue, across 2 reported segments.
- The next-largest line, Paper, is a distant second at 19.74% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Packaging80.26%
Paper19.74%
Quote time 2026-10-08 07:00:20 · For reference only, not investment advice and not tailored to your situation.